U.S. Preeclampsia Laboratory Testing Market is Forecasted to Reach a Market Value Worth US$3,040.5 Mn by 2026, at a decent CAGR of 5.1% LONDON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- High blood pressure and signs that other organs such as the liver and kidneys are damaged are key identifiers of preeclampsia in patients. Hospitals,...